Description
An inhibitor of 5α-reductase type II (IC50 = 4.2 nM); 100-fold selective for 5α-reductase type II over type I; does not affect the growth of androgen-refractory PC3 prostate cancer cells but increases the protein levels of Nrf2 and HO-1; decreases prostatic diameter and volume, as well as dihydrotestosterone serum levels in dogs with spontaneous benign prostatic hypertrophy at 0.1 and 0.5 mg/kg; reduces testosterone-induced type I procollagen and TGF-β1 protein levels in cultured human scalp dermal fibroblasts in a model of androgenic alopecia at 0.1 µM
Formal name: (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
Synonyms: MK-906
Molecular weight: 372.5
CAS: 98319-26-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Lipid Biochemistry|Sterol Lipids